Kidney damage predictors in children with metabolically healthy and metabolically unhealthy obesity phenotype

Int J Obes (Lond). 2023 Dec;47(12):1247-1255. doi: 10.1038/s41366-023-01379-1. Epub 2023 Sep 9.

Abstract

Background: Obesity and kidney damage have been closely linked in adults, but little is still known in childhood.

Objective: To identify predictors of kidney damage in children with metabolically healthy (MHO) and metabolically unhealthy (MUO) obesity phenotypes.

Methods: We retrospectively examined 396 children with obesity (mean age 10.72 ± 2.71 years, body mass index-standard deviation score, BMI-SDS, 2.23 ± 0.57) stratified according to metabolic phenotypes. Kidney damage was defined as the presence of reduced estimated glomerular filtration rate (eGFR < 90 mL/min/1.73m2) and/or albuminuria (≥ 30 mg/g urinary creatinine).

Results: Kidney damage was found in 20.9% of the study population. Children with kidney damage had higher BMI-SDS, homeostasis model assessment of insulin resistance (HOMA-IR), and inflammation markers levels and increased prevalence of non-alcoholic fatty liver disease (NAFLD) than those without kidney damage (all p < 0.005). MUO and MHO subjects had respectively an odds ratio (OR) to show kidney damage of of 1.92 (95%CI:1.22-3.01; p = 0.005) and 1.05 (95%CI:1.00-1.09; p = 0.028) after adjustments. Moreover, we found that only HOMA-IR was closely associated to kidney damage in MUO group (OR = 2.07;95%CI:1.20-3.57; p = 0.007), while HOMA-IR (OR = 1.15;95%CI:1.02-1.29; p = 0.011) and uric acid (OR = 1.15;95% CI:1.02-1.30; p = 0.010) were the only significant risk factors for kidney damage in MHO group.

Conclusion: An increased risk of kidney damage has been observed in children with obesity and in particular in those with MUO phenotype. As their role on kidney function, HOMA-IR should be monitored in MUO children and both HOMA-IR and uric acid in MHO children.

MeSH terms

  • Adolescent
  • Adult
  • Body Mass Index
  • Child
  • Humans
  • Kidney
  • Kidney Diseases*
  • Metabolic Syndrome* / epidemiology
  • Obesity / complications
  • Obesity / epidemiology
  • Phenotype
  • Retrospective Studies
  • Risk Factors
  • Uric Acid

Substances

  • Uric Acid